nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS2—Doxorubicin—liver cancer	0.225	0.333	CbGbCtD
Metformin—NDUFS7—Doxorubicin—liver cancer	0.225	0.333	CbGbCtD
Metformin—NDUFS3—Doxorubicin—liver cancer	0.225	0.333	CbGbCtD
Metformin—ND4L—gall bladder—liver cancer	0.00377	0.0387	CbGeAlD
Metformin—ND5—gall bladder—liver cancer	0.00377	0.0387	CbGeAlD
Metformin—ND3—gall bladder—liver cancer	0.00377	0.0387	CbGeAlD
Metformin—ND2—gall bladder—liver cancer	0.00377	0.0387	CbGeAlD
Metformin—ND4—gall bladder—liver cancer	0.00365	0.0375	CbGeAlD
Metformin—ND6—gall bladder—liver cancer	0.00329	0.0338	CbGeAlD
Metformin—NDUFS4—gall bladder—liver cancer	0.00302	0.031	CbGeAlD
Metformin—NDUFA8—gall bladder—liver cancer	0.00294	0.0302	CbGeAlD
Metformin—NDUFB8—gall bladder—liver cancer	0.00289	0.0297	CbGeAlD
Metformin—ND6—embryo—liver cancer	0.00209	0.0215	CbGeAlD
Metformin—NDUFA5—embryo—liver cancer	0.00202	0.0208	CbGeAlD
Metformin—NDUFS1—embryo—liver cancer	0.00199	0.0205	CbGeAlD
Metformin—NDUFB4—embryo—liver cancer	0.00189	0.0194	CbGeAlD
Metformin—NDUFB9—embryo—liver cancer	0.00186	0.0192	CbGeAlD
Metformin—NDUFA4—embryo—liver cancer	0.00185	0.019	CbGeAlD
Metformin—NDUFB11—embryo—liver cancer	0.00184	0.0189	CbGeAlD
Metformin—ND1—gall bladder—liver cancer	0.00184	0.0189	CbGeAlD
Metformin—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00179	0.0283	CcSEcCtD
Metformin—Respiratory distress—Sorafenib—liver cancer	0.00165	0.0262	CcSEcCtD
Metformin—NDUFV3—liver—liver cancer	0.00159	0.0164	CbGeAlD
Metformin—NDUFS6—liver—liver cancer	0.00155	0.0159	CbGeAlD
Metformin—NDUFA7—liver—liver cancer	0.00151	0.0155	CbGeAlD
Metformin—SLC29A4—liver—liver cancer	0.00144	0.0148	CbGeAlD
Metformin—NDUFAF3—liver—liver cancer	0.00141	0.0145	CbGeAlD
Metformin—Rhinorrhoea—Sorafenib—liver cancer	0.0013	0.0205	CcSEcCtD
Metformin—NDUFA9—liver—liver cancer	0.00126	0.013	CbGeAlD
Metformin—NDUFA13—liver—liver cancer	0.00126	0.013	CbGeAlD
Metformin—NDUFA1—liver—liver cancer	0.00124	0.0128	CbGeAlD
Metformin—NDUFV2—liver—liver cancer	0.00121	0.0124	CbGeAlD
Metformin—ND4L—liver—liver cancer	0.0011	0.0114	CbGeAlD
Metformin—ND5—liver—liver cancer	0.0011	0.0114	CbGeAlD
Metformin—ND3—liver—liver cancer	0.0011	0.0114	CbGeAlD
Metformin—ND2—liver—liver cancer	0.0011	0.0114	CbGeAlD
Metformin—ND4—liver—liver cancer	0.00107	0.011	CbGeAlD
Metformin—NDUFA2—liver—liver cancer	0.00105	0.0108	CbGeAlD
Metformin—NDUFA10—liver—liver cancer	0.000999	0.0103	CbGeAlD
Metformin—NDUFC1—liver—liver cancer	0.00099	0.0102	CbGeAlD
Metformin—Neuropathy—Sorafenib—liver cancer	0.000987	0.0156	CcSEcCtD
Metformin—NDUFB2—liver—liver cancer	0.000982	0.0101	CbGeAlD
Metformin—NDUFAF1—liver—liver cancer	0.000974	0.01	CbGeAlD
Metformin—ND6—liver—liver cancer	0.000966	0.00992	CbGeAlD
Metformin—NDUFAF2—liver—liver cancer	0.000958	0.00984	CbGeAlD
Metformin—NDUFB3—liver—liver cancer	0.000958	0.00984	CbGeAlD
Metformin—NDUFA5—liver—liver cancer	0.000936	0.00961	CbGeAlD
Metformin—NDUFA11—liver—liver cancer	0.000936	0.00961	CbGeAlD
Metformin—Tooth abscess—Epirubicin—liver cancer	0.00093	0.0147	CcSEcCtD
Metformin—NDUFAF4—liver—liver cancer	0.000929	0.00954	CbGeAlD
Metformin—NDUFB6—liver—liver cancer	0.000929	0.00954	CbGeAlD
Metformin—NDUFS1—liver—liver cancer	0.000922	0.00947	CbGeAlD
Metformin—NDUFB10—liver—liver cancer	0.000915	0.00941	CbGeAlD
Metformin—NDUFB7—liver—liver cancer	0.000909	0.00934	CbGeAlD
Metformin—NDUFA12—liver—liver cancer	0.000909	0.00934	CbGeAlD
Metformin—NDUFB1—liver—liver cancer	0.000903	0.00927	CbGeAlD
Metformin—NDUFS8—liver—liver cancer	0.000903	0.00927	CbGeAlD
Metformin—NDUFA6—liver—liver cancer	0.000891	0.00915	CbGeAlD
Metformin—NDUFB5—liver—liver cancer	0.000891	0.00915	CbGeAlD
Metformin—NDUFS4—liver—liver cancer	0.000885	0.00909	CbGeAlD
Metformin—NDUFB4—liver—liver cancer	0.000873	0.00897	CbGeAlD
Metformin—NDUFAB1—liver—liver cancer	0.000868	0.00892	CbGeAlD
Metformin—NDUFA8—liver—liver cancer	0.000862	0.00886	CbGeAlD
Metformin—NDUFB9—liver—liver cancer	0.000862	0.00886	CbGeAlD
Metformin—Tooth abscess—Doxorubicin—liver cancer	0.00086	0.0136	CcSEcCtD
Metformin—NDUFA4—liver—liver cancer	0.000857	0.00881	CbGeAlD
Metformin—NDUFB11—liver—liver cancer	0.000852	0.00875	CbGeAlD
Metformin—NDUFV1—liver—liver cancer	0.000852	0.00875	CbGeAlD
Metformin—NDUFB8—liver—liver cancer	0.000847	0.0087	CbGeAlD
Metformin—NDUFS5—liver—liver cancer	0.000847	0.0087	CbGeAlD
Metformin—NDUFS7—liver—liver cancer	0.000794	0.00815	CbGeAlD
Metformin—Pain in extremity—Sorafenib—liver cancer	0.000763	0.0121	CcSEcCtD
Metformin—PRKAB1—liver—liver cancer	0.000726	0.00746	CbGeAlD
Metformin—Dehydration—Sorafenib—liver cancer	0.000709	0.0112	CcSEcCtD
Metformin—Abdominal pain upper—Sorafenib—liver cancer	0.000697	0.011	CcSEcCtD
Metformin—Body temperature decreased—Epirubicin—liver cancer	0.000693	0.011	CcSEcCtD
Metformin—Hypothermia—Epirubicin—liver cancer	0.000693	0.011	CcSEcCtD
Metformin—Breast disorder—Sorafenib—liver cancer	0.000689	0.0109	CcSEcCtD
Metformin—NDUFC2—liver—liver cancer	0.000684	0.00703	CbGeAlD
Metformin—Nasopharyngitis—Sorafenib—liver cancer	0.000682	0.0108	CcSEcCtD
Metformin—NDUFS2—liver—liver cancer	0.000658	0.00676	CbGeAlD
Metformin—NDUFS3—liver—liver cancer	0.00065	0.00667	CbGeAlD
Metformin—Pancreatitis—Sorafenib—liver cancer	0.000646	0.0102	CcSEcCtD
Metformin—Hypothermia—Doxorubicin—liver cancer	0.000641	0.0101	CcSEcCtD
Metformin—Body temperature decreased—Doxorubicin—liver cancer	0.000641	0.0101	CcSEcCtD
Metformin—Abdominal discomfort—Sorafenib—liver cancer	0.000632	0.01	CcSEcCtD
Metformin—SLC22A3—embryo—liver cancer	0.000632	0.00649	CbGeAlD
Metformin—Neutropenia—Sorafenib—liver cancer	0.000617	0.00975	CcSEcCtD
Metformin—Nail disorder—Epirubicin—liver cancer	0.000599	0.00947	CcSEcCtD
Metformin—Infestation NOS—Sorafenib—liver cancer	0.000588	0.0093	CcSEcCtD
Metformin—Infestation—Sorafenib—liver cancer	0.000588	0.0093	CcSEcCtD
Metformin—Neuropathy peripheral—Sorafenib—liver cancer	0.000576	0.00911	CcSEcCtD
Metformin—Hepatobiliary disease—Sorafenib—liver cancer	0.000556	0.00879	CcSEcCtD
Metformin—Nail disorder—Doxorubicin—liver cancer	0.000554	0.00876	CcSEcCtD
Metformin—ND1—liver—liver cancer	0.00054	0.00554	CbGeAlD
Metformin—Connective tissue disorder—Sorafenib—liver cancer	0.000519	0.0082	CcSEcCtD
Metformin—Fungal infection—Epirubicin—liver cancer	0.000503	0.00795	CcSEcCtD
Metformin—Flushing—Sorafenib—liver cancer	0.00049	0.00775	CcSEcCtD
Metformin—Cardiac disorder—Sorafenib—liver cancer	0.00049	0.00775	CcSEcCtD
Metformin—Angiopathy—Sorafenib—liver cancer	0.000479	0.00757	CcSEcCtD
Metformin—Immune system disorder—Sorafenib—liver cancer	0.000477	0.00754	CcSEcCtD
Metformin—Rigors—Epirubicin—liver cancer	0.000476	0.00752	CcSEcCtD
Metformin—Mediastinal disorder—Sorafenib—liver cancer	0.000476	0.00752	CcSEcCtD
Metformin—Fungal infection—Doxorubicin—liver cancer	0.000465	0.00736	CcSEcCtD
Metformin—Blood disorder—Epirubicin—liver cancer	0.000465	0.00735	CcSEcCtD
Metformin—Malnutrition—Sorafenib—liver cancer	0.000459	0.00726	CcSEcCtD
Metformin—Erythema—Sorafenib—liver cancer	0.000459	0.00726	CcSEcCtD
Metformin—Dysgeusia—Sorafenib—liver cancer	0.00045	0.00711	CcSEcCtD
Metformin—Muscle spasms—Sorafenib—liver cancer	0.000442	0.00698	CcSEcCtD
Metformin—Rigors—Doxorubicin—liver cancer	0.00044	0.00696	CcSEcCtD
Metformin—Blood disorder—Doxorubicin—liver cancer	0.00043	0.0068	CcSEcCtD
Metformin—Syncope—Sorafenib—liver cancer	0.000412	0.00652	CcSEcCtD
Metformin—Loss of consciousness—Sorafenib—liver cancer	0.000404	0.00639	CcSEcCtD
Metformin—Hypertension—Sorafenib—liver cancer	0.000397	0.00627	CcSEcCtD
Metformin—Myalgia—Sorafenib—liver cancer	0.000391	0.00619	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000388	0.00614	CcSEcCtD
Metformin—Infection—Sorafenib—liver cancer	0.000373	0.00589	CcSEcCtD
Metformin—Shock—Sorafenib—liver cancer	0.000369	0.00583	CcSEcCtD
Metformin—Nervous system disorder—Sorafenib—liver cancer	0.000368	0.00581	CcSEcCtD
Metformin—Thrombocytopenia—Sorafenib—liver cancer	0.000367	0.00581	CcSEcCtD
Metformin—SLC47A1—liver—liver cancer	0.000367	0.00377	CbGeAlD
Metformin—Neuropathy—Epirubicin—liver cancer	0.000365	0.00577	CcSEcCtD
Metformin—Skin disorder—Sorafenib—liver cancer	0.000364	0.00576	CcSEcCtD
Metformin—Anorexia—Sorafenib—liver cancer	0.000357	0.00565	CcSEcCtD
Metformin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000342	0.0054	CcSEcCtD
Metformin—Neuropathy—Doxorubicin—liver cancer	0.000337	0.00534	CcSEcCtD
Metformin—Dyspnoea—Sorafenib—liver cancer	0.000334	0.00529	CcSEcCtD
Metformin—Dyspepsia—Sorafenib—liver cancer	0.00033	0.00522	CcSEcCtD
Metformin—Decreased appetite—Sorafenib—liver cancer	0.000326	0.00515	CcSEcCtD
Metformin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000324	0.00512	CcSEcCtD
Metformin—Fatigue—Sorafenib—liver cancer	0.000323	0.00511	CcSEcCtD
Metformin—Constipation—Sorafenib—liver cancer	0.000321	0.00507	CcSEcCtD
Metformin—Gastrointestinal pain—Sorafenib—liver cancer	0.000307	0.00485	CcSEcCtD
Metformin—SLC22A1—liver—liver cancer	0.000306	0.00314	CbGeAlD
Metformin—Urticaria—Sorafenib—liver cancer	0.000298	0.00471	CcSEcCtD
Metformin—Abdominal pain—Sorafenib—liver cancer	0.000296	0.00469	CcSEcCtD
Metformin—Renal impairment—Epirubicin—liver cancer	0.000296	0.00468	CcSEcCtD
Metformin—SLC22A3—liver—liver cancer	0.000292	0.003	CbGeAlD
Metformin—Hypoglycaemia—Epirubicin—liver cancer	0.000289	0.00457	CcSEcCtD
Metformin—Lethargy—Epirubicin—liver cancer	0.000288	0.00455	CcSEcCtD
Metformin—Pain in extremity—Epirubicin—liver cancer	0.000282	0.00446	CcSEcCtD
Metformin—Migraine—Epirubicin—liver cancer	0.000278	0.00439	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—liver cancer	0.000274	0.00433	CcSEcCtD
Metformin—Asthenia—Sorafenib—liver cancer	0.000269	0.00425	CcSEcCtD
Metformin—Hypoglycaemia—Doxorubicin—liver cancer	0.000267	0.00423	CcSEcCtD
Metformin—Lethargy—Doxorubicin—liver cancer	0.000266	0.00421	CcSEcCtD
Metformin—Pruritus—Sorafenib—liver cancer	0.000265	0.00419	CcSEcCtD
Metformin—Dehydration—Epirubicin—liver cancer	0.000262	0.00415	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—liver cancer	0.000261	0.00413	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—liver cancer	0.00026	0.00412	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—liver cancer	0.000258	0.00407	CcSEcCtD
Metformin—Migraine—Doxorubicin—liver cancer	0.000257	0.00406	CcSEcCtD
Metformin—Diarrhoea—Sorafenib—liver cancer	0.000257	0.00406	CcSEcCtD
Metformin—Breast disorder—Epirubicin—liver cancer	0.000255	0.00403	CcSEcCtD
Metformin—Nasopharyngitis—Epirubicin—liver cancer	0.000252	0.00399	CcSEcCtD
Metformin—Dizziness—Sorafenib—liver cancer	0.000248	0.00392	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—liver cancer	0.000245	0.00388	CcSEcCtD
Metformin—Influenza—Epirubicin—liver cancer	0.000244	0.00385	CcSEcCtD
Metformin—Dehydration—Doxorubicin—liver cancer	0.000243	0.00384	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—liver cancer	0.000241	0.00381	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—liver cancer	0.000239	0.00378	CcSEcCtD
Metformin—Vomiting—Sorafenib—liver cancer	0.000238	0.00377	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—liver cancer	0.000238	0.00377	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—liver cancer	0.000237	0.00375	CcSEcCtD
Metformin—Rash—Sorafenib—liver cancer	0.000236	0.00374	CcSEcCtD
Metformin—Dermatitis—Sorafenib—liver cancer	0.000236	0.00374	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—liver cancer	0.000236	0.00373	CcSEcCtD
Metformin—Headache—Sorafenib—liver cancer	0.000235	0.00371	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—liver cancer	0.000233	0.00369	CcSEcCtD
Metformin—Neutropenia—Epirubicin—liver cancer	0.000228	0.0036	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—liver cancer	0.000227	0.00359	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000226	0.00358	CcSEcCtD
Metformin—Influenza—Doxorubicin—liver cancer	0.000225	0.00357	CcSEcCtD
Metformin—Nausea—Sorafenib—liver cancer	0.000223	0.00352	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—liver cancer	0.000221	0.0035	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—liver cancer	0.00022	0.00347	CcSEcCtD
Metformin—Infestation—Epirubicin—liver cancer	0.000217	0.00344	CcSEcCtD
Metformin—Drowsiness—Epirubicin—liver cancer	0.000217	0.00344	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—liver cancer	0.000217	0.00344	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—liver cancer	0.000213	0.00337	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—liver cancer	0.000211	0.00333	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00021	0.00331	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—liver cancer	0.000205	0.00325	CcSEcCtD
Metformin—Infestation—Doxorubicin—liver cancer	0.000201	0.00318	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—liver cancer	0.000201	0.00318	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—liver cancer	0.000201	0.00318	CcSEcCtD
Metformin—Bradycardia—Epirubicin—liver cancer	0.000199	0.00314	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000197	0.00312	CcSEcCtD
Metformin—Rhinitis—Epirubicin—liver cancer	0.000196	0.00309	CcSEcCtD
Metformin—Hepatitis—Epirubicin—liver cancer	0.000195	0.00308	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—liver cancer	0.000194	0.00307	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—liver cancer	0.000192	0.00304	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—liver cancer	0.000192	0.00303	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—liver cancer	0.00019	0.00301	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—liver cancer	0.000184	0.00291	CcSEcCtD
Metformin—Eye disorder—Epirubicin—liver cancer	0.000182	0.00288	CcSEcCtD
Metformin—Flushing—Epirubicin—liver cancer	0.000181	0.00286	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—liver cancer	0.000181	0.00286	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—liver cancer	0.000181	0.00286	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—liver cancer	0.00018	0.00285	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—liver cancer	0.00018	0.00284	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—liver cancer	0.000178	0.00281	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—liver cancer	0.000177	0.0028	CcSEcCtD
Metformin—Angiopathy—Epirubicin—liver cancer	0.000177	0.0028	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—liver cancer	0.000176	0.00279	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—liver cancer	0.000176	0.00278	CcSEcCtD
Metformin—Chills—Epirubicin—liver cancer	0.000175	0.00277	CcSEcCtD
Metformin—Erythema—Epirubicin—liver cancer	0.00017	0.00268	CcSEcCtD
Metformin—Malnutrition—Epirubicin—liver cancer	0.00017	0.00268	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—liver cancer	0.000169	0.00267	CcSEcCtD
Metformin—Flushing—Doxorubicin—liver cancer	0.000167	0.00265	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—liver cancer	0.000167	0.00265	CcSEcCtD
Metformin—Flatulence—Epirubicin—liver cancer	0.000167	0.00265	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—liver cancer	0.000166	0.00263	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—liver cancer	0.000164	0.00259	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—liver cancer	0.000163	0.00258	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—liver cancer	0.000163	0.00258	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—liver cancer	0.000163	0.00257	CcSEcCtD
Metformin—Chills—Doxorubicin—liver cancer	0.000162	0.00256	CcSEcCtD
Metformin—Vision blurred—Epirubicin—liver cancer	0.00016	0.00253	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—liver cancer	0.000158	0.00249	CcSEcCtD
Metformin—Erythema—Doxorubicin—liver cancer	0.000157	0.00248	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—liver cancer	0.000157	0.00248	CcSEcCtD
Metformin—Flatulence—Doxorubicin—liver cancer	0.000155	0.00245	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—liver cancer	0.000154	0.00243	CcSEcCtD
Metformin—Malaise—Epirubicin—liver cancer	0.000153	0.00242	CcSEcCtD
Metformin—Syncope—Epirubicin—liver cancer	0.000152	0.00241	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—liver cancer	0.000151	0.00239	CcSEcCtD
Metformin—Palpitations—Epirubicin—liver cancer	0.00015	0.00237	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—liver cancer	0.000149	0.00236	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—liver cancer	0.000148	0.00234	CcSEcCtD
Metformin—Hypertension—Epirubicin—liver cancer	0.000147	0.00232	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—liver cancer	0.000146	0.00231	CcSEcCtD
Metformin—Myalgia—Epirubicin—liver cancer	0.000145	0.00229	CcSEcCtD
Metformin—Chest pain—Epirubicin—liver cancer	0.000145	0.00229	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000144	0.00227	CcSEcCtD
Metformin—Discomfort—Epirubicin—liver cancer	0.000143	0.00226	CcSEcCtD
Metformin—Malaise—Doxorubicin—liver cancer	0.000142	0.00224	CcSEcCtD
Metformin—Syncope—Doxorubicin—liver cancer	0.000141	0.00223	CcSEcCtD
Metformin—Palpitations—Doxorubicin—liver cancer	0.000139	0.0022	CcSEcCtD
Metformin—Oedema—Epirubicin—liver cancer	0.000139	0.00219	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—liver cancer	0.000138	0.00218	CcSEcCtD
Metformin—Infection—Epirubicin—liver cancer	0.000138	0.00218	CcSEcCtD
Metformin—Shock—Epirubicin—liver cancer	0.000136	0.00216	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—liver cancer	0.000136	0.00215	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—liver cancer	0.000136	0.00215	CcSEcCtD
Metformin—Hypertension—Doxorubicin—liver cancer	0.000136	0.00214	CcSEcCtD
Metformin—Skin disorder—Epirubicin—liver cancer	0.000135	0.00213	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—liver cancer	0.000134	0.00212	CcSEcCtD
Metformin—Chest pain—Doxorubicin—liver cancer	0.000134	0.00212	CcSEcCtD
Metformin—Myalgia—Doxorubicin—liver cancer	0.000134	0.00212	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000133	0.0021	CcSEcCtD
Metformin—Discomfort—Doxorubicin—liver cancer	0.000132	0.00209	CcSEcCtD
Metformin—Anorexia—Epirubicin—liver cancer	0.000132	0.00209	CcSEcCtD
Metformin—Hypotension—Epirubicin—liver cancer	0.000129	0.00205	CcSEcCtD
Metformin—Oedema—Doxorubicin—liver cancer	0.000128	0.00203	CcSEcCtD
Metformin—Infection—Doxorubicin—liver cancer	0.000127	0.00201	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000126	0.002	CcSEcCtD
Metformin—Shock—Doxorubicin—liver cancer	0.000126	0.00199	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—liver cancer	0.000126	0.00199	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—liver cancer	0.000126	0.00199	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—liver cancer	0.000125	0.00197	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—liver cancer	0.000124	0.00197	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—liver cancer	0.000124	0.00196	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—liver cancer	0.000124	0.00195	CcSEcCtD
Metformin—Somnolence—Epirubicin—liver cancer	0.000123	0.00195	CcSEcCtD
Metformin—Anorexia—Doxorubicin—liver cancer	0.000122	0.00193	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—liver cancer	0.000122	0.00193	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—liver cancer	0.00012	0.0019	CcSEcCtD
Metformin—Hypotension—Doxorubicin—liver cancer	0.00012	0.00189	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00012	0.00189	CcSEcCtD
Metformin—Fatigue—Epirubicin—liver cancer	0.000119	0.00189	CcSEcCtD
Metformin—Constipation—Epirubicin—liver cancer	0.000118	0.00187	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000117	0.00185	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—liver cancer	0.000115	0.00182	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—liver cancer	0.000114	0.00181	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—liver cancer	0.000114	0.00181	CcSEcCtD
Metformin—Somnolence—Doxorubicin—liver cancer	0.000114	0.0018	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—liver cancer	0.000113	0.00179	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—liver cancer	0.000113	0.00178	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—liver cancer	0.000111	0.00176	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000111	0.00175	CcSEcCtD
Metformin—Fatigue—Doxorubicin—liver cancer	0.000111	0.00175	CcSEcCtD
Metformin—Urticaria—Epirubicin—liver cancer	0.00011	0.00174	CcSEcCtD
Metformin—Constipation—Doxorubicin—liver cancer	0.00011	0.00173	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—liver cancer	0.00011	0.00173	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—liver cancer	0.000106	0.00167	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000105	0.00166	CcSEcCtD
Metformin—Urticaria—Doxorubicin—liver cancer	0.000102	0.00161	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—liver cancer	0.000101	0.0016	CcSEcCtD
Metformin—Asthenia—Epirubicin—liver cancer	9.94e-05	0.00157	CcSEcCtD
Metformin—Pruritus—Epirubicin—liver cancer	9.8e-05	0.00155	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—liver cancer	9.48e-05	0.0015	CcSEcCtD
Metformin—Asthenia—Doxorubicin—liver cancer	9.2e-05	0.00145	CcSEcCtD
Metformin—Dizziness—Epirubicin—liver cancer	9.16e-05	0.00145	CcSEcCtD
Metformin—Pruritus—Doxorubicin—liver cancer	9.07e-05	0.00143	CcSEcCtD
Metformin—Vomiting—Epirubicin—liver cancer	8.81e-05	0.00139	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—liver cancer	8.77e-05	0.00139	CcSEcCtD
Metformin—Rash—Epirubicin—liver cancer	8.74e-05	0.00138	CcSEcCtD
Metformin—Dermatitis—Epirubicin—liver cancer	8.73e-05	0.00138	CcSEcCtD
Metformin—Headache—Epirubicin—liver cancer	8.68e-05	0.00137	CcSEcCtD
Metformin—Dizziness—Doxorubicin—liver cancer	8.48e-05	0.00134	CcSEcCtD
Metformin—Nausea—Epirubicin—liver cancer	8.23e-05	0.0013	CcSEcCtD
Metformin—Vomiting—Doxorubicin—liver cancer	8.15e-05	0.00129	CcSEcCtD
Metformin—Rash—Doxorubicin—liver cancer	8.08e-05	0.00128	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—liver cancer	8.08e-05	0.00128	CcSEcCtD
Metformin—Headache—Doxorubicin—liver cancer	8.03e-05	0.00127	CcSEcCtD
Metformin—Nausea—Doxorubicin—liver cancer	7.62e-05	0.0012	CcSEcCtD
Metformin—ND1—Metabolism—CYP1A1—liver cancer	1.43e-05	8.65e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NAT2—liver cancer	1.42e-05	8.61e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ALB—liver cancer	1.41e-05	8.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALDOB—liver cancer	1.36e-05	8.25e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—MTHFR—liver cancer	1.33e-05	8.07e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CB—liver cancer	1.33e-05	8.06e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CB—liver cancer	1.33e-05	8.06e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CB—liver cancer	1.33e-05	8.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—RAF1—liver cancer	1.33e-05	8.06e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARA—liver cancer	1.3e-05	7.91e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CRABP1—liver cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKCE—liver cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—PPARA—liver cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—liver cancer	1.26e-05	7.62e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CB—liver cancer	1.25e-05	7.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—RAF1—liver cancer	1.24e-05	7.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF2—liver cancer	1.23e-05	7.46e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—liver cancer	1.22e-05	7.39e-05	CbGpPWpGaD
Metformin—SLC22A2—SLC-mediated transmembrane transport—ALB—liver cancer	1.19e-05	7.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CYCS—liver cancer	1.16e-05	7.03e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—liver cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—liver cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—liver cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—liver cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CSF2—liver cancer	1.15e-05	6.96e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—liver cancer	1.14e-05	6.89e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HPGDS—liver cancer	1.13e-05	6.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—H2AFX—liver cancer	1.13e-05	6.86e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CG—liver cancer	1.12e-05	6.78e-05	CbGpPWpGaD
Metformin—SLC22A1—SLC-mediated transmembrane transport—ALB—liver cancer	1.11e-05	6.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CPT1B—liver cancer	1.1e-05	6.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GLUL—liver cancer	1.1e-05	6.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CYCS—liver cancer	1.08e-05	6.55e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—liver cancer	1.08e-05	6.54e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—liver cancer	1.07e-05	6.48e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NR1H4—liver cancer	1.06e-05	6.46e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA3—liver cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GLUL—liver cancer	1.03e-05	6.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CPT1B—liver cancer	1.03e-05	6.24e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—liver cancer	1.03e-05	6.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—liver cancer	1.02e-05	6.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—RAF1—liver cancer	1.02e-05	6.17e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSMA4—liver cancer	1.01e-05	6.13e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSMD10—liver cancer	1.01e-05	6.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—HMOX1—liver cancer	1.01e-05	6.11e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NR1H4—liver cancer	9.92e-06	6.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GOT2—liver cancer	9.84e-06	5.97e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—liver cancer	9.82e-06	5.96e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA3—liver cancer	9.76e-06	5.92e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—liver cancer	9.69e-06	5.88e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—liver cancer	9.64e-06	5.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA4—liver cancer	9.57e-06	5.81e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—liver cancer	9.52e-06	5.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—RAF1—liver cancer	9.48e-06	5.75e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—liver cancer	9.39e-06	5.7e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—liver cancer	9.39e-06	5.7e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—liver cancer	9.39e-06	5.7e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—liver cancer	9.39e-06	5.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.39e-06	5.7e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—liver cancer	9.36e-06	5.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA2—liver cancer	9.33e-06	5.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK14—liver cancer	9.3e-06	5.64e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2E1—liver cancer	9.25e-06	5.61e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—liver cancer	9.12e-06	5.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—F2—liver cancer	9.01e-06	5.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA1—liver cancer	9e-06	5.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA4—liver cancer	8.92e-06	5.41e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NAT2—liver cancer	8.9e-06	5.4e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—liver cancer	8.73e-06	5.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RAF1—liver cancer	8.72e-06	5.29e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA2—liver cancer	8.7e-06	5.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYCS—liver cancer	8.65e-06	5.25e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—liver cancer	8.62e-06	5.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—liver cancer	8.62e-06	5.23e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—liver cancer	8.56e-06	5.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDOB—liver cancer	8.53e-06	5.18e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GOT1—liver cancer	8.49e-06	5.15e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GGT1—liver cancer	8.49e-06	5.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA1—liver cancer	8.39e-06	5.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NAT2—liver cancer	8.3e-06	5.03e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CRABP1—liver cancer	8.14e-06	4.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	8.14e-06	4.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—liver cancer	8.1e-06	4.92e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—liver cancer	8.1e-06	4.91e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—liver cancer	8.1e-06	4.91e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—liver cancer	8.1e-06	4.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDOB—liver cancer	7.95e-06	4.83e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—liver cancer	7.78e-06	4.72e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—liver cancer	7.63e-06	4.63e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—liver cancer	7.61e-06	4.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CRABP1—liver cancer	7.59e-06	4.6e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	7.58e-06	4.6e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—liver cancer	7.58e-06	4.6e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—liver cancer	7.52e-06	4.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SERPINE1—liver cancer	7.49e-06	4.55e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	7.31e-06	4.44e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—liver cancer	7.11e-06	4.32e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—liver cancer	7.01e-06	4.25e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	6.81e-06	4.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAF1—liver cancer	6.76e-06	4.1e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A1—liver cancer	6.64e-06	4.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—liver cancer	6.63e-06	4.02e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—liver cancer	6.61e-06	4.01e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—liver cancer	6.61e-06	4.01e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—liver cancer	6.61e-06	4.01e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—liver cancer	6.6e-06	4.01e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—liver cancer	6.6e-06	4.01e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSMA4—liver cancer	6.34e-06	3.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSMD10—liver cancer	6.34e-06	3.85e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—liver cancer	6.22e-06	3.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—liver cancer	6.2e-06	3.76e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—liver cancer	6.19e-06	3.76e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GOT2—liver cancer	6.17e-06	3.74e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARA—liver cancer	6.08e-06	3.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—liver cancer	6.07e-06	3.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—liver cancer	6.07e-06	3.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	6.05e-06	3.67e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—liver cancer	5.91e-06	3.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSMA4—liver cancer	5.91e-06	3.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSMD10—liver cancer	5.91e-06	3.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—liver cancer	5.9e-06	3.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—liver cancer	5.86e-06	3.55e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2E1—liver cancer	5.8e-06	3.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GOT2—liver cancer	5.75e-06	3.49e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—liver cancer	5.74e-06	3.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—liver cancer	5.72e-06	3.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	5.64e-06	3.42e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—liver cancer	5.6e-06	3.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK8—liver cancer	5.58e-06	3.39e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.47e-06	3.32e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYCS—liver cancer	5.43e-06	3.29e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2E1—liver cancer	5.41e-06	3.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GOT1—liver cancer	5.33e-06	3.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GGT1—liver cancer	5.33e-06	3.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—liver cancer	5.22e-06	3.17e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—liver cancer	5.22e-06	3.17e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—liver cancer	5.2e-06	3.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—liver cancer	5.15e-06	3.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—liver cancer	5.1e-06	3.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	5.1e-06	3.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYCS—liver cancer	5.06e-06	3.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—liver cancer	5.02e-06	3.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GGT1—liver cancer	4.96e-06	3.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GOT1—liver cancer	4.96e-06	3.01e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—liver cancer	4.78e-06	2.9e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—liver cancer	4.74e-06	2.88e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—liver cancer	4.73e-06	2.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—liver cancer	4.72e-06	2.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—liver cancer	4.57e-06	2.78e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—liver cancer	4.52e-06	2.74e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—liver cancer	4.46e-06	2.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—liver cancer	4.4e-06	2.67e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—liver cancer	4.4e-06	2.67e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—liver cancer	4.38e-06	2.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—liver cancer	4.26e-06	2.59e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A1—liver cancer	4.17e-06	2.53e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—liver cancer	4.1e-06	2.49e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—liver cancer	4.03e-06	2.44e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—liver cancer	3.99e-06	2.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—liver cancer	3.9e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—liver cancer	3.88e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A1—liver cancer	3.88e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARA—liver cancer	3.81e-06	2.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—liver cancer	3.73e-06	2.26e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—liver cancer	3.62e-06	2.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—liver cancer	3.57e-06	2.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARA—liver cancer	3.55e-06	2.16e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—liver cancer	3.29e-06	2e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—liver cancer	3.26e-06	1.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—liver cancer	3.15e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—liver cancer	3.04e-06	1.85e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—liver cancer	2.94e-06	1.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—liver cancer	2.87e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—liver cancer	2.83e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—liver cancer	2.67e-06	1.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—liver cancer	2.64e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—liver cancer	2.5e-06	1.52e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—liver cancer	2.43e-06	1.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—liver cancer	2.33e-06	1.41e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—liver cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—liver cancer	1.52e-06	9.25e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—liver cancer	1.42e-06	8.62e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—liver cancer	1.25e-06	7.56e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—liver cancer	1.16e-06	7.04e-06	CbGpPWpGaD
